Search results for "Adenocarcinoma"

showing 10 items of 589 documents

Synchronous parenchymal renal tumors of different histology in the same kidney

2009

Background: Synchronous primary cortical tumors of different histology in the same kidney are rare. Preoperative awareness of this coexistence is important, since it can help in planning the surgical approach. Purpose: To describe the imaging findings observed in five patients with two parenchymal malignant tumors of different histology in the same kidney. Material and Methods: We reviewed the pathology reports of 381 patients operated for renal tumors from January 2000 to March 2007. The medical records of all patients with multiple, synchronous, primary lesions of different histology in the same kidney were reviewed with special attention to imaging findings and indications on the nature…

AdultMalemedicine.medical_specialtyPathologyContrast MediaRenal tumorImagingDifferent subtypeNeoplasms Multiple PrimaryRetrospective StudieParenchymaCarcinomamedicineHumansRadiology Nuclear Medicine and imagingCarcinoma Renal CellRetrospective StudiesAgedAged 80 and overKidneyRadiological and Ultrasound Technologybusiness.industryMedical recordMultifocalityKidney NeoplasmHistologyRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseKidney NeoplasmsCarcinoma Papillarymedicine.anatomical_structureAdenocarcinomaFemaleRadiologybusinessTomography X-Ray ComputedKidney diseaseAdenocarcinoma Clear CellHuman
researchProduct

Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus.

2007

Abstract BACKGROUND: The development of oesophageal adenocarcinoma is generally closely associated with the presence of a specialised intestinal-type epithelium such as that found in Barrett's oesophagus (BO). A particular histological condition is when the distal oesophagus showing cardiac and/or fundic mucosa without intestinal metaplasia cannot be defined as 'Barrett's mucosa' [condition that we call 'columnar-lined oesophagus' (CLO)] and up till now, there has been no agreement in literature about the management of this condition. Aurora-A overexpression leads to centrosome amplification, chromosomal instability and aneuploidy in mammalian cells. PATIENTS AND METHODS: A prospective stud…

AdultMalemedicine.medical_specialtyPathologyEsophageal NeoplasmsSettore MED/06 - Oncologia MedicaAneuploidySettore BIO/11 - Biologia MolecolareAdenocarcinomaProtein Serine-Threonine KinasesSettore MED/08 - Anatomia PatologicaGastroenterologyBarrett EsophagusAurora KinasesInternal medicineBiopsymedicineHumansAurora-A overexpression Barrett’s oesophagus cell cycle columnar-lined oesophagus p53 proteinProspective StudiesEsophagusMucous Membranemedicine.diagnostic_testEsophageal diseasebusiness.industryIntestinal metaplasiaHematologyMiddle Agedmedicine.diseasemedicine.anatomical_structureOncologyDysplasiaBarrett's esophagusGastroesophageal RefluxFemalebusinessImmunostainingBiomarkers
researchProduct

Multiple Peptide Hormone Producing Adenocarcinoma of Lung with Neurotensin and CRF-like Immunoreactivity

1988

Summary A pulmonary cancer of a 43 year-old-man was classified according to WHO-criteria as a poorly differentiated adenocarcinoma because of demonstration of mucinous substances in tumor cells and in rarely occurring acinar lumina. Immunohistochemical reactivity for several peptide hormones was detected in the predominant solid parts of the carcinoma. In many tumor cells an immunoreactivity to neurotensin, bombesin and — according to the elevated serum levels — to ACTH, CRF and calcitonin was found. Therefore the present lung cancer must be defined as a combined carcinoma composed of mucous producing and endocrine cell types. Because peptide hormone production is not restricted to the clas…

AdultMalemedicine.medical_specialtyPathologyLung NeoplasmsCorticotropin-Releasing HormoneEnteroendocrine cellAdenocarcinomaPeptide hormoneBiologyPathology and Forensic Medicinechemistry.chemical_compoundInternal medicinemedicineCarcinomaHumansLung cancerNeurotensinBombesinCell Biologymedicine.diseaseImmunohistochemistryEndocrinologychemistryCalcitoninHormones EctopicAdenocarcinomahormones hormone substitutes and hormone antagonistsNeurotensinPathology - Research and Practice
researchProduct

Do we truly see what we think we see? The role of cognitive bias in pathological interpretation

2008

In the histomorphological grading of prostate carcinoma, pathologists have regularly assigned comparable scores for the architectural Gleason and the now-obsolete nuclear World Health Organization (WHO) grading systems. Although both systems demonstrate good correspondence between grade and survival, they are based on fundamentally different biological criteria. We tested the hypothesis that this apparent concurrence between the two grading systems originates from an interpretation bias in the minds of diagnostic pathologists, rather than reflecting a biological reality. Three pathologists graded 178 prostatectomy specimens, assigning Gleason and WHO scores on glass slides and on digital im…

AdultMalemedicine.medical_specialtyPathologymedicine.medical_treatmentAdenocarcinomaPathology and Forensic MedicineCognitionImage Processing Computer-AssistedmedicineHumansDiagnostic ErrorsGrading (education)PathologicalAgedProportional Hazards ModelsCell NucleusProstatectomyPathology Clinicalbusiness.industryProstatectomyProstateProstatic NeoplasmsAnatomical pathologyCognitionProstate carcinomaMiddle AgedPrognosisCognitive biasTumor recurrenceROC CurveClinical CompetenceRadiologybusinessPrejudiceThe Journal of Pathology
researchProduct

A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagoga…

2009

The combination of irinotecan with 5-fluorouracil demonstrates efficacy with tolerable safety in the first-line treatment of metastatic gastroesophageal cancer (mGC). This randomized phase II trial compared for the first time capecitabine with irinotecan or cisplatin in this setting.Patients were randomly assigned to receive 3-week cycles of capecitabine 1000 mg/m(2), twice daily for 14 days, with on day 1 either irinotecan 250 mg/m(2) (XI) or cisplatin 80 mg/m(2) (XP). The primary end point was overall response rate (ORR) and secondary end points included progression-free survival (PFS), overall survival (OS) and safety.Of 118 patients recruited, 112 were eligible for safety analysis and 1…

AdultMalemedicine.medical_specialtyPhases of clinical researchKaplan-Meier EstimateAdenocarcinomaIrinotecanDeoxycytidineGastroenterologyCapecitabineStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProgression-free survivalStomach cancerCapecitabineAgedbusiness.industryCombination chemotherapyHematologyMiddle Agedmedicine.diseaseSurgeryIrinotecanRegimenOncologyFluorouracilCamptothecinFemaleEsophagogastric JunctionFluorouracilCisplatinbusinessmedicine.drugAnnals of Oncology
researchProduct

Prognostic Factors Determining Long-Term Survival in Well-Differentiated Thyroid Cancer: An Analysis of Four Hundred Eighty-Four Patients Undergoing …

2003

Identification of the prognostic factors relevant for long-term survival in differentiated thyroid cancer in a homogenously treated patient cohort in order to allow a better initial risk stratification.Four hundred eighty-four (358 females/126 males) patients with differentiated thyroid cancer (330 papillary [68.2%]; 154 follicular [31.8%]) were included. Inclusion criteria consisted of treatment with a uniform therapy scheme and continuous aftercare in the same institution. Initial diagnosis was between 1975-1995 (age at diagnosis, 14-84 years, median, 49.7). Tumor stage: pT1, n = 92; pT2, 211; pT3, 58; pT4, 123. Low-risk:or=pT3 NX M0, 331; high-risk pT4 and/or M1, 153. After thyroidectomy…

AdultMalemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentEndocrinologyRecurrenceCause of DeathInternal medicineAdenocarcinoma FollicularFollicular phaseLong term survivalmedicineHumansSurvivorsThyroid NeoplasmsThyroid cancerAgedNeoplasm StagingRetrospective StudiesCause of deathAged 80 and overbusiness.industryWell-Differentiated Thyroid CancerThyroidectomyRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryAdenocarcinoma PapillaryCohortFemalebusinessFollow-Up StudiesThyroid
researchProduct

Nephron-sparing surgery of renal cell carcinoma with a normal opposite kidney: long-term outcome in 180 patients

2000

Abstract Objectives. To investigate the long-term outcome of an organ-saving approach for renal cell carcinoma (RCC) with a normal opposite kidney (elective indication). Methods. Since 1979, 180 patients have undergone nephron-sparing surgery at our institution for RCC in the presence of a normal contralateral kidney. The mean age was 56 years (range 23 to 83), and the mean follow-up was 4.7 years (maximum 14.8). Most of these tumors were found incidentally, with a mean tumor diameter on ultrasound of 3.3 cm (range 1.0 to 8.6). Results. The postoperative course was unremarkable in 173 patients. Postoperative bleeding was encountered in 4 patients and urinary extravasation in an additional 3…

AdultMalemedicine.medical_specialtyUrologyNephronNephrectomyPostoperative ComplicationsRenal cell carcinomaCarcinomaHumansMedicineCarcinoma Renal CellSurvival rateAgedAged 80 and overKidneybusiness.industryUltrasoundMiddle Agedmedicine.diseaseKidney NeoplasmsSurgerySurvival RateTreatment Outcomemedicine.anatomical_structureAdenocarcinomaFemalebusinessFollow-Up StudiesKidney diseaseUrology
researchProduct

Influence of identification and preservation of pelvic autonomic nerves in rectal cancer surgery on bladder dysfunction after total mesorectal excisi…

2003

PURPOSE: Given the improvement in oncologic outcome after the introduction of total mesorectal excision for the treatment of rectal cancer, the objective of the present study was to determine the frequency of identification and preservation of the pelvic autonomic nerves and to identify a possible link between postoperative micturition disturbances and the extent of the radical resection. METHODS: Between March 1997 and December 2001, 150 patients with adenocarcinoma of the rectum (≤16 cm from the anal verge) underwent surgery, with sphincter preservation in 112 cases (74.7 percent). Sixty-three patients (42 percent) were classified as American Society of Anesthesiologists Stage III and two…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectUrinary systemRectumAdenocarcinomaUrinationNeurosurgical Proceduresmedicine.nerveHypogastric nervePostoperative ComplicationsSuperior hypogastric plexusMedicineHumansTrauma Nervous SystemUrinary Bladder NeurogenicColectomymedia_commonAgedUltrasonographyAged 80 and overUrinary bladderHypogastric Plexusbusiness.industryRectal NeoplasmsGastroenterologyHypogastric PlexusGeneral MedicineMiddle AgedTotal mesorectal excisionSurgerymedicine.anatomical_structureFemalebusinessDiseases of the colon and rectum
researchProduct

Invisible gastric carcinoma detected by random biopsy: long-term results after photodynamic therapy

2008

Background and study aims Gastric cancer diagnosed from routine gastric biopsies without any evidence of a visible lesion and negative repeated biopsies is an infrequent but serious clinical problem for which gastrectomy has usually been recommended, even if operative specimens do not show cancer either. We report on a series of 22 such patients undergoing long-term follow-up after attempted treatment with photodynamic therapy (PDT). Patients and methods 22 patients with invisible gastric cancer (IGC) who presented during a 10-year period (10 men, mean age 56 +/- 15 years) were prospectively included. Initial histopathological findings confirmed by second opinion included 10 well-differenti…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPhotodynamic therapyGastric carcinomaAdenocarcinomaStomach NeoplasmsBiopsymedicineCarcinomaHumansAgedPhotosensitizing Agentsmedicine.diagnostic_testSignet ring cellbusiness.industryBiopsy NeedleStomachSecond opinionGastroenterologyCancerMiddle Agedmedicine.diseaseSurgeryTreatment OutcomePhotochemotherapyFemaleGastrectomybusinessCarcinoma Signet Ring CellEndoscopy
researchProduct

Vinorelbine and Cisplatin for the Treatment of Recurrent and/or Metastatic Carcinoma of the Uterine Cervix

2002

<i>Background:</i> To test the clinical activity and toxicity profile of the combination regimen of vinorelbine and cisplatin in a series of patients with carcinoma of the cervix uteri with de novo metastatic disease or recurrent disease after previous therapy. The main aims of the study included analysis of objective response rates, toxicity, and time to progression. <i>Patients and Methods:</i> Forty-two eligible patients were enrolled into the trial and treated with cisplatin 80 mg/m<sup>2</sup> on day 1 and vinorelbine 25 mg/m<sup>2</sup> on day 1 and 8. This regimen was repeated every 21 days upon resolution of toxicity for 3 cycles befor…

AdultOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentUterine Cervical NeoplasmsVinblastineVinorelbineMetastatic carcinomaRecurrenceInternal medicineAntineoplastic Combined Chemotherapy ProtocolsCarcinomaHumansMedicineNeoplasm MetastasisCervixAgedCisplatinChemotherapyurogenital systembusiness.industryVinorelbineGeneral MedicineMiddle Agedmedicine.diseaseSurgeryRegimenTreatment Outcomemedicine.anatomical_structureOncologyAdenocarcinomaFemaleCisplatinbusinessmedicine.drugOncology
researchProduct